JPMorgan Raises BioNTech PT to $121 from $116, Maintains Neutral Rating. - AInvest

Retrieved on: 2025-09-22 12:39:58

Tags for this article:

Click the tags to see associated articles and topics

JPMorgan Raises BioNTech PT to $121 from $116, Maintains Neutral Rating. - AInvest. View article details on hiswai:

Excerpt

JPMorgan Chase & Co. has updated its price target for BioNTech SE (NASDAQ: BNTX) to $121 from $116, while maintaining a neutral rating on the ...

Article found on: www.ainvest.com